Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function

Transplantation

Volumn 66, Issue 1, 1998, Pages 38-43

  Mckenna, Rachel M ^a,b   Lee, Kingsley R ^a   Gough, James C ^a   Jeffery, John R ^a   Grimm, Paul C ^a   Rush, David N ^a   Nickerson, Peter ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DILTIAZEM; EPITOPE; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE;

ARTICLE; GRAFT SURVIVAL; HLA MATCHING; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CROSS REACTIONS; EPITOPES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032528029     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00006     Document Type: Article

References (38)

1. Opelz G for the Collaborative Transplant Study. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants. Transplant Proc 1987; 19: 641.
2. Gjertson DW, Terasaki PI, Takemoto S, Mickey HR. National allocation of cadaveric kidneys by HLA matching: projected effect on outcome and costs. N Engl J Med 1991; 324: 1032.
3. Kerman RH, Kimball PM, Lindholm A, et al. Influence of HLA matching on rejection and short- and long-term primary cadaveric allograft survival. Transplantation 1993; 56: 1242.
4. Held PJ, Kahan BD, Hunsicker LG, et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med 1994; 331: 765.
5. Takemoto S, Gjertson DW, Terasaki PI. HLA matching: a comparison of conventional and molecular approaches. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 413.
6. Thompson JS, Thacker LR. CREG matching for first cadaveric kidney transplants (TNX) performed by SEOPF centers between October 1987 and September 1995. Clin Transplant 1996; 10: 586.
7. The effect of HLA matching on cadavers renal allograft survival: a multivariate analysis of conventional, CREG and amino acid residue matching. A UNOS report for the U.S. Department of Health and Human Services. Richmond, VA: United Network for Organ Sharing, 1996.
8. Almond P, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
9. Massy ZA, Guijarro C, Kasiske BL. Clinical predictors of chronic allograft rejection. Kidney Int 1995; 48: S52.
10. Flechner S, Modlin C, Serrano D, et al. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation 1996; 62: 1235.
11. Kobayashi T, Yokoyama I, Uchida K, et al. The significance of HLA-DRB1 matching in clinical renal transplantation. Transplantation 1992; 54: 238.
12. Kobayashi T, Yokoyama I, Uchida K, Orihara A, Takagi H. HLA-DRB1 matching as a recipient selection criterion in cadaveric renal transplantation. Transplantation 1993; 55:1294.
13. Beckingham IJ, Dennis MJS, Bishop MC, Blarney RW, Smith SJ, Nicholson ML. Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation. Br J Surg 1994; 81: 574.
14. Nickerson P, Jeffery J, Gough J, et al. The identification of clinical and histological risk factors for diminished renal function 2 years post-transplant. J Am Soc Nephrol 1998; 9: 482.
15. Solez K, Axelsen R, Benediktsson H, et al. International standardization of criteria for the histological diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
16. Takemoto S, Terasaki PI, Gjertson DW, Cecka JM. Equitable allocation of HLA-compatible kidneys for local pools and for minorities. N Engl J Med 1994; 331: 760.
17. Takemoto S, Gjertson DW, Cecka JM, Terasaki PI. HLA matching for local pools using fewer HLA factors. Transplant Proc 1995; 27: 675.
18. Starzl TE, Eliasziw M, Gjertson D, et al. HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation 1997; 64: 983.
19. Opelz G, Mytilineos J, Scherer S, et al. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991; 338: 461.
20. Connolly JK, Dyer PA, Martin S, Parrott NR, Pearson RC, Johnson RWG. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation 1996; 61: 709.
21. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995; 346: 1318.
22. Thorogood J, Persijn GG, Schreuder GM, et al. The effect of HLA matching on kidney graft survival in separate post-transplantation intervals. Transplantation 1990; 50: 146.
23. Gilks WR, Gore SM, Bradley BA. Renal transplant rejection: transient immunodominance of HLA mismatches. Transplantation 1990; 50: 141.
24. Zantvoort FA, D'Amaro J, Persijn GG, et al. The impact of HLA matching on long-term survival of renal allografts. Transplantation 1996; 61: 841.
25. Vanrenterghem Y, Roels L, Waer M, et al. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy. Transplant Proc 1987; 19: 685.
26. Christiaans MHL, Van Den Berg-Looner PM, Peltewburg HG, Leunissen KML, van Hooff JP. More favorable clinical course in kidney allograft recipients due to HLA-B + DR matching. Transplant Proc 1991; 23: 2674.
27. Constanzo-Nordin MR, Fisher SG, O'Sullivan EJ, et al. HLA-DR incompatibility predicts heart transplant rejection indepen-dent of immunosuppressive prophylaxis. J Heart Lung Transplant 1993; 12: 779.
28. Sheldon S, Hasleton PS, Yowan NA, et al. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation 1994; 58: 719.
29. Rodey GE, Fuller TC. Public epitopes and the antigenic structure of HLA molecules. CRC Crit Rev Immunol 1987; 7: 229.
30. Parham P, Lawlor DA, Salter RD, et al. HLA-A, B, C: patterns of polymorphism in peptide binding proteins. In: Dupont B, ed. Immunobiology of HLA, Vol. II. New York: Springer-Verlag, 1989: 10.
31. Fuller AA, Trevithick JE, Rodey GE, Parham P, Fuller TC. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum Immunol 1990; 282: 284.
32. Fuller AA, Rodey GE, Parham P, Fuller TC. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes. Hum Immunol 1990; 28: 306.
33. Colombani J. Conserved and variable structures in HLA class I molecules: a review. Tissue Antigens 1990; 35: 103.
34. Park MS, Barbetti AA, Geer L, et al. HLA epitopes selected by serology. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 515.
35. Park MS, Clark BD, Maruya E, Terasaki PI. HLA class I epitopes accounted for by single residues. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 335.
36. Sanfilippo F, Vaughn WK, Spees EK, Heise ER, Lefor WM. The effect of HLA-A, -B matching on cadaver renal allograft rejection comparing public and private specificities. Transplantation 1984; 38: 483.
37. Zhang L, van Bree S, van Rood JI, Claas FHJ. The effect of individual HLA-A and B mismatches on the generation of cytotoxic T lymphocyte precursors. Transplantation 1990; 50: 1008.
38. Takemoto S, Terasaki PI. HLA epitopes and graft survival. In: Terasaki PI. ed. Clinical transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 363.